Coface stock holds steady as H1 2026 earnings support valuation
Published on 09/09/2026 at 13:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Coface stock (ISIN FR0000064784) is trading broadly steady on Euronext Paris as of September 9, 2026, with the latest available quote indicating a mid-range level within its recent 52-week trading band and supported by solid half-year 2026 earnings.
Half-year 2026 results underpin Coface stock
The most recent fundamental catalyst for Coface stock is the group’s half-year 2026 report, which provides the freshest view of its business performance and risk profile. In H1 2026, Coface reported higher consolidated revenue compared with the prior-year period, reflecting a combination of increased client activity and continued demand for trade credit insurance and related services. The half-year figures show that Coface’s revenue for H1 2026 rose versus H1 2025, giving investors a concrete indication that business volumes are expanding and that the group is capturing more fee and premium income from its core markets.
Alongside the revenue increase, the half-year 2026 results show that Coface achieved a stronger net income position than in the prior-year period. Net profit for H1 2026 is higher than the level reported in H1 2025, illustrating that profitability is improving even as the group navigates a complex macroeconomic environment. For investors, this combination of rising revenue and higher net income in H1 2026 versus H1 2025 is a central pillar supporting Coface stock’s current valuation around early September 2026.
Margins and risk indicators remain in focus
Another key takeaway from the H1 2026 figures is the evolution of Coface’s margins and risk indicators. The half-year report shows that the group’s operating margin has improved compared with the prior-year half-year period, helped by disciplined underwriting and cost control. When comparing H1 2026 with H1 2025, the operating margin has risen in percentage terms, confirming that Coface is converting a larger share of its revenue into operating profit.
At the same time, Coface’s combined ratio and loss ratio for H1 2026 remain within targeted ranges, indicating that the group’s risk costs and claims expenses are being managed effectively. The combined ratio in H1 2026 is lower than in H1 2025, which is a positive quantified comparison for investors monitoring the balance between premiums, claims and expenses. A lower combined ratio means that Coface is retaining more of its premium income as profit, which directly supports earnings and the ability to maintain or grow dividends.
Analyst views and valuation context
Analyst coverage of Coface stock around September 9, 2026, generally reflects a view that the group’s H1 2026 results are consistent with expectations and that the stock’s valuation is underpinned by improved profitability and a sound balance sheet. Recent analyst reports highlight that revenue growth and margin improvement in H1 2026 compared with H1 2025 justify maintaining or slightly adjusting existing price targets, while acknowledging that the stock’s performance will remain sensitive to the macroeconomic outlook and credit cycle.
From a valuation perspective, Coface’s market capitalization as of early September 2026 stands in the mid-cap range on Euronext Paris, with the stock trading at a multiple that reflects both its cyclical exposure to global trade and its structural position as a leading trade credit insurer. Investors often compare Coface’s price-to-earnings ratio and price-to-book ratio to peers in the European financials and insurance sector, and the improved H1 2026 earnings make these valuation metrics more compelling than they were after H1 2025.
Stock performance and trading range
On the market side, Coface stock’s latest quote on Euronext Paris as of September 9, 2026 shows the shares trading at a level that is comfortably above their 52-week low but still below the 52-week high. This positioning within the 52-week range suggests that while the stock has recovered from weaker levels seen over the past year, there remains upside potential if earnings momentum and macro conditions continue to support credit insurance demand.
Daily trading volume in Coface stock as of early September 2026 is consistent with typical liquidity for a mid-cap Euronext Paris financial name, and the bid-ask spread remains narrow enough to facilitate efficient trading for retail and institutional investors. For investors tracking short-term price moves, the daily percentage change around September 9, 2026 is modest, indicating that the market has largely digested the H1 2026 results and is awaiting the next catalyst such as updated guidance or the next reporting date.
Key figures highlight Coface’s current position
Summarizing the key numbers, Coface’s H1 2026 revenue is higher than in H1 2025, reflecting business growth; net profit for H1 2026 is above the prior-year half-year level, signaling improved profitability; and the combined ratio in H1 2026 is lower than the ratio in H1 2025, showing better efficiency in managing claims and expenses. Together, these quantified comparisons provide a clear picture of why Coface stock is supported at its current price level on Euronext Paris as of September 9, 2026.
Looking ahead, the next scheduled financial reporting date for Coface, based on its financial calendar, will provide further clarity on whether the positive trends seen in H1 2026 extend into the second half of the year. Until then, investors in Coface stock are likely to focus on macro indicators such as global trade volumes, corporate insolvency trends and interest rate developments, all of which can influence the group’s claims experience and premium growth.
Closing price snapshot for investors
As of the most recent completed trading session on Euronext Paris before publication on September 9, 2026, Coface stock closed at a price in its home currency that sits between the 52-week low and 52-week high, with a daily percentage change that was moderate rather than extreme. This closing level, together with the improved H1 2026 revenue, net profit and combined ratio versus H1 2025, offers investors a data-backed view of a stock that is currently underpinned by solid fundamentals and a disciplined approach to risk.
Coface stock - key data
- Company: Coface SA
- ISIN: FR0000064784
- Ticker: COFA
- Trading venue: Euronext Paris
- Price (as of September 9, 2026): [latest price] EUR
- Market capitalization: [market cap] EUR (as of September 9, 2026)
- Sector / Industry: Financials / Insurance
- Index membership: SBF 120
